Identification and characterization of Cardiac Glycosides as senolytic compounds
Senolytic compounds have the ability to eliminate senescent cells from tissues and have been shown to be beneficial in various animal models of age-related diseases. Here the authors show that cardiac glycosides commonly used for heart diseases have senolytic properties in humanized mouse models of...
Enregistré dans:
Auteurs principaux: | Francisco Triana-Martínez, Pilar Picallos-Rabina, Sabela Da Silva-Álvarez, Federico Pietrocola, Susana Llanos, Verónica Rodilla, Enrica Soprano, Pablo Pedrosa, Alba Ferreirós, Marta Barradas, Fernanda Hernández-González, Marta Lalinde, Neus Prats, Cristina Bernadó, Patricia González, María Gómez, Maria P. Ikonomopoulou, Pablo J. Fernández-Marcos, Tomás García-Caballero, Pablo del Pino, Joaquín Arribas, Anxo Vidal, Miguel González-Barcia, Manuel Serrano, María I. Loza, Eduardo Domínguez, Manuel Collado |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/76f6dda146f1406681b8658e9fa1302e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Author Correction: Identification and characterization of Cardiac Glycosides as senolytic compounds
par: Francisco Triana-Martínez, et autres
Publié: (2020) -
Senolytic Therapy for Cerebral Ischemia-Reperfusion Injury
par: Songhyun Lim, et autres
Publié: (2021) -
Senolytics: A Novel Strategy for Neuroprotection in ALS?
par: Alexandra Maximova, et autres
Publié: (2021) -
Evaluating the neuroprotective impact of senolytic drugs on human vision
par: Nevin W. El-Nimri, et autres
Publié: (2020) -
Identification of HSP90 inhibitors as a novel class of senolytics
par: Heike Fuhrmann-Stroissnigg, et autres
Publié: (2017)